Impact of Asthma Exacerbations

Asthma Attack Clinical Trial

— IMPAX  

Official title:

Impact of Asthma Exacerbations: A Qualitative Study

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT04410120
• Other study ID #: 20038
• Status: Not yet recruiting
• Start date: September 2020
• Est. completion date: September 2020

Study information

• Verified date: May 2020
• Source: University of Nottingham
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of the study is to gain a deeper understanding of the impact of asthma attacks on the lives of patients who experience them. This will help us to describe the true extent of the impact of asthma attacks on factors of importance to patients which have not previously been well described, including the psychological, social, financial and emotional burden of asthma attacks.

Additionally, it is hoped that detailed questioning regarding features of asthma attacks from a patient perspective will improve our understanding of patient recognition of attacks, consistency of certain features of attacks and patient views regarding preventative strategies for attacks. Patient experiences of asthma attacks are poorly described in previous research. Hence this work is expected to provide useful insights into these experiences which will contribute to improvements in detecting, treating and preventing asthma attacks.

The study will consist of a one-off interview lasting about 45 minutes with patients who have recently had asthma attacks. We plan to recruit patients for the study from an outpatient clinic for those who have had a recent attack or from a register of patients who have volunteered for future asthma research studies. The interviews will take place in person at the Respiratory Research Unit at the Nottingham City Hospital or over the telephone depending on patient preference.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 30
• Est. completion date: September 2020
• Est. primary completion date: September 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 16 Years and older

Eligibility

Inclusion Criteria:

• Adults with previous clinician diagnosis of asthma (16 years and above)

• Recent (=4 weeks) asthma attack for which patient received =3 days of systemic corticosteroid treatment

Exclusion Criteria:

• Anyone under the age of 16 years.

• Anyone unable to speak or understand English.

Related Conditions & MeSH terms

• Asthma
• Asthma Attack

Intervention

Other:
• Interview
Semi-structured 45 minute interviews regarding impact of asthma attacks

Locations

Country	Name	City	State
United Kingdom	Nottingham Respiratory Research Unit	Nottingham	Nottinghamshire

Sponsors (1)

Lead Sponsor	Collaborator
University of Nottingham

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Thematic analysis of interview transcripts using framework approach	Thematic analysis of interview transcripts using framework approach	One off 45 minute interview